S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
These are the Top 4 Stocks for Buybacks in 2024
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
These are the Top 4 Stocks for Buybacks in 2024
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
These are the Top 4 Stocks for Buybacks in 2024
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
These are the Top 4 Stocks for Buybacks in 2024
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China

Cardiol Therapeutics (CRDL) Earnings Date, Estimates & Call Transcripts

$1.67
-0.08 (-4.57%)
(As of 04/18/2024 ET)
Skip Charts & View Estimated and Actual Earnings Data

CRDL Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

CRDL Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Cardiol Therapeutics Analyst EPS Estimates

Current Year EPS Consensus Estimate:($0.31) EPS
Next Year EPS Consensus Estimate: ($0.29) EPS

CRDL Earnings Date and Information

Cardiol Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, May 20th, 2024 based off prior year's report dates.

Cardiol Therapeutics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
5/20/2024
Estimated)
------- 
11/14/2023Q3 2023($0.09)($0.07)+$0.02($0.07)--
8/10/2023Q2 2023-($0.09)($0.09)($0.09)--
5/15/2023Q1 2023-($0.08)($0.08)($0.08)--
3/28/2023Q4 2022-($0.09)($0.09)($0.09)--
11/10/2022Q3 2022-($0.10)($0.10)($0.10)--
8/10/2022Q2 2022-($0.08)($0.08)($0.08)--
5/16/2022Q1 2022-($0.11)($0.11)($0.11)--
3/23/2022Q4 2021-($0.09)($0.09)($0.09)--
11/15/2021Q3 2021-($0.18)($0.18)($0.18)--
8/16/2021Q2 2021-($0.13)($0.13)($0.13)-$0.06 million

Cardiol Therapeutics Earnings - Frequently Asked Questions

When is Cardiol Therapeutics's earnings date?

Cardiol Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, May 20th, 2024 based off last year's report dates. Learn more on CRDL's earnings history.

How much revenue does Cardiol Therapeutics generate each year?

Cardiol Therapeutics (NASDAQ:CRDL) has a recorded annual revenue of $60,000.00.

How much profit does Cardiol Therapeutics generate each year?

Cardiol Therapeutics (NASDAQ:CRDL) has a recorded net income of -$20.84 million. CRDL has generated -$0.33 earnings per share over the last four quarters.

What is Cardiol Therapeutics's EPS forecast for next year?

Cardiol Therapeutics's earnings are expected to grow from ($0.31) per share to ($0.29) per share in the next year.


More Earnings Resources from MarketBeat

This page (NASDAQ:CRDL) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners